
Immunotherapy for the Treatment of Non-Small Cell Lung Cancer
Diagnosis for NSCLC
Diagnosis for NSCLC
- Prior to initiation of immunotherapy, tests recommended by the majority of the Task Force included computerized tomography (CT) of the chest, abdomen, and pelvis and thyroid function tests (in addition to routine lab tests).
Table 1. PD-L1 Assay Characteristics and Performance in NSCLC
...L1 Assay Characteristics and Performance in...
Treatment for NSCLC
...Treatment fo...
Figure 1. Advanced/Metastatic NSCLC Treatment Algorithm
...1. Advanced/Metastatic NSCLC Treatment Algorithm...
...testing for all newly diagnosed patient...
...line pembrolizumab monotherapy should be use...
...ients with squamous histology and PD-L1...
For patients with non-squamous, advanced NSCLC...
...zumab, nivolumab, or pembrolizumab (TPS â‰...
...with non-squamous, advanced NSCLC with PD-L1 T...
...lizumab is recommended first-line in patient...
...ould be used in stage III patients who have n...
Monitoring for NSCLC
...Monitori...
...and Monitoring Radiographic Respon...
...nizing, Monitoring and Managing Treatment-R...
...2. FDA-approved Programmed Cell Deat...